Nautilus Biotechnology, Inc.NAUTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-59M

+16.6% YoY

Free Cash Flow

$-52M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	-3	-3↓20.2%	-6↓67.0%	-6↓11.4%	-6↓1.8%
Operating Income	-50	-64↓26.0%	-76↓19.7%	-81↓7.0%	-67↑18.0%
Net Income	-50	-58↓15.1%	-64↓9.9%	-71↓11.2%	-59↑16.6%
EBITDA	-47	-55↓14.8%	-74↓36.3%	-64↑13.3%	-53↑18.5%
EPS Diluted	-0.60	-0.46↑23.3%	-0.51↓10.9%	-0.56↓9.8%	-0.47↑16.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	186	115↓38.3%	19↓83.1%	28↑42.5%	12↓55.2%
Total Current Assets	349	187↓46.4%	177↓5.5%	133↓24.9%	106↓20.2%
Total Assets	398	350↓12.1%	306↓12.7%	243↓20.6%	191↓21.3%
Total Current Liabilities	6	7↑16.8%	9↑34.3%	8↓16.3%	8↑4.2%
Total Liabilities	35	35↑0.7%	40↑14.5%	34↓15.4%	34↑0.4%
Total Equity	364	315↓13.4%	265↓15.7%	209↓21.3%	157↓24.8%
Total Debt	30	30↑1.0%	35↑14.2%	30↓12.0%	30↓1.5%
Net Debt	-156	-84↑45.9%	15↑118.1%	3↓81.4%	18↑522.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-39	-46↓16.7%	-52↓12.9%	-59↓14.4%	-51↑14.3%
Capital Expenditure	-2	-2↓2.4%	-2↓5.1%	-2↑13.1%	-1↑39.8%
Free Cash Flow	-42	-48↓15.9%	-54↓12.5%	-61↓13.1%	-52↑15.2%
Stock-Based Comp	8	10↑30.8%	12↑16.9%	13↑4.6%	7↓46.1%
Net Change in Cash	149	-71↓147.6%	-95↓33.9%	8↑108.7%	-15↓285.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance